Phase IIa Study of F-1311 in Patients with Prostate Cancer
Phase 2
Completed
- Conditions
- Prostate cancer
- Registration Number
- JPRN-jRCT2080222723
- Lead Sponsor
- PDRadiopharma Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Male
- Target Recruitment
- 15
Inclusion Criteria
Biopsy confirmed presence of adenocarcinoma of the prostate gland.
-Gleason score >= 7
-PSA > 20 ng/m
Exclusion Criteria
-Subjects have received or have been receiving treatment or medication for prostate cancer.
-Subjects have severe hepatic or renal dysfunction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy<br>Ability of F-1311 to accumulate in prostate cancer
- Secondary Outcome Measures
Name Time Method safety<br>Adverse events